Cargando…
Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
Pediatric high-grade gliomas (pHGG) are a molecularly diverse group of malignancies, each incredibly aggressive and in dire need of treatment advancements. Genomic analysis has revolutionized our understanding of these tumors, identifying biologically relevant subgroups with differing canonical muta...
Autores principales: | Groves, Andrew, Cooney, Tabitha M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795020/ https://www.ncbi.nlm.nih.gov/pubmed/36589742 http://dx.doi.org/10.3389/fcell.2022.1089898 |
Ejemplares similares
-
Epigenetic Regulation of Autophagy Beyond the Cytoplasm: A Review
por: Shi, Yin, et al.
Publicado: (2021) -
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
por: Karandikar, Paramesh V., et al.
Publicado: (2023) -
Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021) -
Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas
por: Zhang, Jingwei, et al.
Publicado: (2022) -
Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas
por: Gu, Yuan, et al.
Publicado: (2020)